Drug Discovery 2022: driving the next life science revolution

Dr Michael Anbar

Dr Michael Anbar
Dr Michael Anbar
Principal Scientist
Horizon Discovery, a PerkinElmer company
Delegate / Speaker

Presentations at Drug Discovery 2022: driving the next life science revolution

Profile of Dr Michael Anbar

Dr. Michael Anbar is a Principal Scientist in the R&D Base Editing team at Horizon Discovery, a PerkinElmer company. Since joining the company in January 2020, his work is focused on developing various components of Pin-point™ and enabling the technology to fulfil its commercial potential. Prior to joining Horizon Discovery, he was a Team Leader and Senior Scientist in the Experimental Haematology Laboratory at the Tel-Aviv University/Beilinson Hospital Research Center (FMRC) in Israel establishing a novel exosome-based immunotherapy platform. Prior to FMRC, he was an R&D Manager at a biotech start-up company leading the efforts for improving the efficiency and production of an engineered multi-enzyme complex for use in commercial-scale bioreactor systems. His post-doctoral research focused on protein engineering of thermostable enzymes.
Michael holds a PhD. in Biochemistry and Molecular Biology from the Weizmann Institute of Science.


Please login to send a Private Message

Hosted By


The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'